HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 23, No 08, August 2019 – Digitalization vs Digitization — Exploring Emerging Trends in Healthcare       » Shanghai neurologists test brain implant to tackle drug addiction       » Gene-editing researchers reduce cancer risk       » Artificial Intelligence in Precision Cancer Diagnostics: Myth or Magic?       » Healing with Technology       » Smart Hospital: An Instrument of Care       » Transforming Healthcare with Data and Artificial Intelligence      
Click here to download ISSUE PDF
Vol 17, No 03, March 2013 - Taiwan Biotech
Contents

EDITORIAL

BioBoard

Australia
•  Well-known antibiotic amoxycillin found to be ineffective cough treatment
•  Bring the noise: has technology made us scared of silence?

India
•  Biocon receives marketing authorization for novel biologic itolizumab for psoriasis

Israel
•  Aspireo reports Somatoprim Phase Ib interim data

Japan
•  Daiichi Sankyo and Amplimmune announce strategic alliance to develop AMP-110 therapy for autoimmune disease
•  Eisai signs agreement with Epizyme and Roche Molecular Systems to develop companion diagnostic

The Philippines
•  Asia-Pacific Analysis: The growth of stem-cell therapy
•  Is the world ready for scientific diplomacy?

United Kingdom
•  ARIAD and the U.K. National Cancer Research Institute to collaborate on SPIRIT 3 clinical study
•  Vision research collaboration on novel treatment for wet age-related macular degeneration

United States
•  Reducing medical mistakes: Two recently published studies support the use of DNA testing on biopsy samples to prevent misdiagnoses
•  CoDa Therapeutics reports positive results from Phase IIb Study of NEXAGON® in chronic venous leg ulcers
•  Inovio Pharmaceuticals to initiate clinical trial for its hepatitis C therapeutic vaccine later this year
•  Jolt to brain eases pain without drugs
•  Can a new vaccine prevent colon cancer?
•  Immunovaccine’s DPX-Survivac produces sustained, dose related immune responses in Phase I ovarian cancer study

Eye on China
•  NCKU researcher develops new use of reservoir sediment
•  WILEX Inc. and GeneDiagnostics Inc. enter into partnership for the IVD approval and distribution of the serum HER-2/neu test
•  Celsion Corporation and Zhejiang Hisun Pharmaceutical Company enter into technology development agreement for ThermoDox® for the Greater China Territory
•  SFDA grants approval for clinical studies to benapenem
•  UroFlex now CE-marked; Chinese SFDA approval for Cellvizio
•  China National Genebank and Smithsonian’s National Museum of Natural History collaborate on biobanking to advance biodiversity research
•  New analytical method for uleine alkaloids having anticancer activity
•  Zhifei Biological’s vaccine approved for clinical test
•  EntreMed files new drug clinical trial application for ENMD-2076 with China SFDA to advance global development strategy

Features
•  The Biotechnology Incubation Center of Academia Sinica: A Gateway to Innovative Taiwan
•  Cancer Targeting Nanomedicine: An Opportunity for Drug Development in Asia with Emphasis on Taiwan
•  Recombinant Lipoproteins for the Development of Novel Subunit Vaccines
•  Discovery of Therapeutic Human Monoclonal Antibodies through B-cell Immortalization Technology

People Watch
•  The Crystal Ball on Biosimilars with Dr. Anthony Rebuck

Inside Industry
•  Cognoptix licenses AD detection technology
•  3D cell culture firm Reinnervate and specialist Oncology CRO Oncotest GmbH enter collaboration agreement
•  Medicago is awarded contract from the U.S. Department of Defence for potential future production
•  Clinical Network Services (CNS) acquires New Zealand partner BELTAS’ business assets
•  VABIOTECH licenses cell-based Japanese encephalitis technology from Inviragen
•  University of Illinois licenses novel anti-cancer therapies to StemPar Sciences
•  Adimab announces new discovery collaboration with Kyowa Hakko Kirin
•  Priaxon enters collaboration with GSK on protein-protein-interactions
•  Lantheus Medical Imaging and FUJIFILM RI Pharma renew long-term license and distribution agreement for Cardiolite and Neurolite in Japan

•  Conference Calendar

NEWS CRUNCH  
news Not Science Fiction anymore — the emergence of AI and Robotics in Healthcare
news How blockchain can save the food industry millions from recalls
news China Healthcare and Pharma Digital Innovation Summit
news BIO-PHARM2019 — The Most Influential Forum in China's Biopharm Industry
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  
SPOTLIGHT  
LIFE OF A SCIENTIST  

APBN Editorial Calendar 2019
January:
Taiwan Medical tourism
February:
Marijuana as medicine — Legal marijuana will open up scientific research
March:
Driven by curiosity
April:
Career developments for researchers
May:
What's cracking — Antibodies in ostrich eggs
June:
Clinical trials — What's in a name?
July:
Traditional Chinese medicine in modern healthcare — Integrating both worlds
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2019 World Scientific Publishing Co Pte Ltd  •  Privacy Policy